178 related articles for article (PubMed ID: 1360983)
1. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
Currier SJ; Kane SE; Willingham MC; Cardarelli CO; Pastan I; Gottesman MM
J Biol Chem; 1992 Dec; 267(35):25153-9. PubMed ID: 1360983
[TBL] [Abstract][Full Text] [Related]
2. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 1993 Feb; 268(5):3143-9. PubMed ID: 8094081
[TBL] [Abstract][Full Text] [Related]
3. Studies of human MDR1-MDR2 chimeras demonstrate the functional exchangeability of a major transmembrane segment of the multidrug transporter and phosphatidylcholine flippase.
Zhou Y; Gottesman MM; Pastan I
Mol Cell Biol; 1999 Feb; 19(2):1450-9. PubMed ID: 9891078
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 1993 Sep; 268(27):19965-72. PubMed ID: 8104183
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes.
Buschman E; Gros P
Mol Cell Biol; 1991 Feb; 11(2):595-603. PubMed ID: 1990275
[TBL] [Abstract][Full Text] [Related]
6. Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1.
Zhang X; Collins KI; Greenberger LM
J Biol Chem; 1995 Mar; 270(10):5441-8. PubMed ID: 7890659
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional characterization of the mouse multidrug resistance gene family.
Dhir R; Buschman E; Gros P
Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
[TBL] [Abstract][Full Text] [Related]
8. mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies.
Buschman E; Arceci RJ; Croop JM; Che M; Arias IM; Housman DE; Gros P
J Biol Chem; 1992 Sep; 267(25):18093-9. PubMed ID: 1381362
[TBL] [Abstract][Full Text] [Related]
9. Structure and expression of the human MDR (P-glycoprotein) gene family.
Chin JE; Soffir R; Noonan KE; Choi K; Roninson IB
Mol Cell Biol; 1989 Sep; 9(9):3808-20. PubMed ID: 2571078
[TBL] [Abstract][Full Text] [Related]
10. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
Devault A; Gros P
Mol Cell Biol; 1990 Apr; 10(4):1652-63. PubMed ID: 1969610
[TBL] [Abstract][Full Text] [Related]
11. Domain exchangeability between the multidrug transporter (MDR1) and phosphatidylcholine flippase (MDR2).
Zhou Y; Gottesman MM; Pastan I
Mol Pharmacol; 1999 Nov; 56(5):997-1004. PubMed ID: 10531406
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of chimeric proteins constructed by exchanging homologous domains of two P-glycoproteins conferring distinct drug resistance profiles.
Dhir R; Gros P
Biochemistry; 1992 Jul; 31(26):6103-10. PubMed ID: 1352702
[TBL] [Abstract][Full Text] [Related]
13. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
Loo TW; Clarke DM
Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
[TBL] [Abstract][Full Text] [Related]
14. Identification of 5' and 3' sequences involved in the regulation of transcription of the human mdr1 gene in vivo.
Madden MJ; Morrow CS; Nakagawa M; Goldsmith ME; Fairchild CR; Cowan KH
J Biol Chem; 1993 Apr; 268(11):8290-7. PubMed ID: 8096520
[TBL] [Abstract][Full Text] [Related]
15. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
Azzaria M; Schurr E; Gros P
Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effects on substrate specificity of independent mutations at the serine939/941 position in predicted transmembrane domain 11 of P-glycoproteins.
Dhir R; Grizzuti K; Kajiji S; Gros P
Biochemistry; 1993 Sep; 32(36):9492-9. PubMed ID: 8103679
[TBL] [Abstract][Full Text] [Related]
17. Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins.
Kino K; Taguchi Y; Yamada K; Komano T; Ueda K
FEBS Lett; 1996 Dec; 399(1-2):29-32. PubMed ID: 8980113
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies.
Yoshimura A; Kuwazuru Y; Sumizawa T; Ichikawa M; Ikeda S; Uda T; Akiyama S
J Biol Chem; 1989 Sep; 264(27):16282-91. PubMed ID: 2476441
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
[TBL] [Abstract][Full Text] [Related]
20. The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein.
Buschman E; Gros P
Cancer Res; 1994 Sep; 54(18):4892-8. PubMed ID: 7915194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
